References

Related publications for ATS products and services
3252 entries

Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab

Alampi MM, Kozlíková M, Mariangeli M, Civita S, Delcanale P, Mussini A, Diaspro A, Bianchini P, Weyergang A, Skarpen E, Berg K, Viappiani C, Abbruzzetti S, Selbo PK (2025) Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab. Biomed Pharmacother 191:118550. doi: 10.1016/j.biopha.2025.118550 PMID: 40946581

Objective: To optimize the cytotoxic efficacy of a photoimmunoconjugate of eosin-5-isothiocyanate and atezolizumab (EITC-atezolizumab) in NSCLC cells; To study the uptake and intracellular transport of atezolizumab; and to evaluate EITC-atezolizumab as a candidate for photochemical internalization (PCI) of the ribosome-inactivating protein gelonin.

Summary: This is the first documentation demonstrating that atezolizumab is transported to CD63-positive organelles, thereby enhancing our understanding of its intracellular trafficking. The study also strengthens the concept of Photoimmunotherapy (PIT) and atezolizumab-based targeting of PD-L1+NSCLCs.

Usage: The cytotoxic efficacy of the PD-L1-targeting immunotoxin (Anti-PD-L1-SAP) was strongly enhanced in PD-L1-positive breast cancer cells by photochemical internalization (PCI),a low-dose, Photodynamictherapy (PDT)-based intracellular drug delivery method.

Related Products: Anti-PD-L1-SAP (Cat. #IT-45)

Focal irradiation regulates distal neural stem and progenitor cell behaviour

Handfield J (2025) Focal irradiation regulates distal neural stem and progenitor cell behaviour. Univ Toronto Thesis.

Objective: To investigate how focal irradiation (IR) impacts non-irradiated neural stem cell (NSC) niches along the neuraxis and whether microglia mediate these long-distance effects.

Summary: Focal cranial IR decreased spinal cord-derived NSCs, while spinal IR reduced neuroblasts and NSCs in the forebrain. Microglia ablation did not rescue these effects, suggesting IR alters NSC behavior along the neuraxis independently of microglia.

Usage: Mac-1-SAP (CD11b, Cat. #IT-06) was cited as a method previously used for microglia ablation.

Related Products: Mac-1-SAP mouse/human (Cat. #IT-06)

See Also:

Investigating anxiety-like behaviors and basolateral amygdala dysfunction in a novel rat model of Parkinson’s disease

Lipari NR (2025) Investigating anxiety-like behaviors and basolateral amygdala dysfunction in a novel rat model of Parkinson’s disease. SUNY Binghamton Thesis.

Objective: To create a unique model of PD with improved face validity, and non-motor symptoms.

Summary: This work helped further characterize motor and non-motor symptoms while providing potential underlying physiological markers for early disease course in a unique animal model of Parkinson’s disease (PD).

Usage: It has been demonstrated that lesioning of the basolateral amygdala with the targeted toxin stable substance P (SSP) saporin, a toxin that selectively lesions neurons which express neurokinin1 receptors, increases anxiety-like behaviors in rats.

Related Products: SSP-SAP (Cat. #IT-11)

See Also:

The dual nature of cold: Unraveling the neural circuits for cool sensing and cold allodynia

Hor CC (2025) The dual nature of cold: Unraveling the neural circuits for cool sensing and cold allodynia. Univ Michigan

Objective: To elucidate the neural mechanisms underlying innocuous cool sensation from the skin to the brain and the spinal circuitry changes that drive cold allodynia under pathological conditions.

Summary: The study identified distinct spinal interneuron populations mediating innocuous cool sensation (Trhr⁺ neurons) and cold allodynia (Tac1⁺/Calb1⁺ neurons). Ablation of these neurons demonstrated their modality-specific contributions, with Trhr⁺ interneurons responsible for cool detection and Tac1⁺/Calb1⁺ neurons for pathological cold hypersensitivity, revealing a spinal circuit basis for temperature discrimination and pain plasticity.

Usage: Bombesin-SAP (IT-40) or Blank-SAP (IT-21) was administered intrathecally at a single dose of 400 ng in 10 µL sterile saline to ablate spinal GRPR⁺ neurons involved in thermal and itch processing.

Related Products: Bombesin-SAP (Cat. #IT-40), Blank-SAP (Cat. #IT-21)

Hole in one: CD137-ADC eliminates GVHD

Nierkens S, Lindemans CA (2025) Hole in one: CD137-ADC eliminates GVHD. Blood 146(9):1038-1040. doi: 10.1182/blood.2025029867 PMID: 40875553

Objective: To show that a single dose of CD137-ADC can prevent acute graft-versus-host disease (GVHD) while pre-serving immune reconstitution in a nonhuman primate (NHP) model of stem cell transplantation.

Summary: Results showed that animals treated with CD137-ADC exhibited markedly reduced clinical and histopathological features of GVHD, improved survival, and, notably, no need for additional immunosuppressive therapy. Although still in preclinical development, these findings support the potential for translation to highly needed human therapy.

Related Products: Saporin (Cat. #PR-01)

See Also:

Assessing the hematological cancer stem cell landscape to improve immunotherapy clinical decisions

Diamantoudis SC, Miliotou AN, Galatou E, Telliou S, Sideris K, Grigoriadis N, Vizirianakis IS (2025) Assessing the hematological cancer stem cell landscape to improve immunotherapy clinical decisions. Biocell doi: 10.32604/biocell.2025.067216

Objective: To combine existing information and clinical evidence to assess and bring to the spotlight targets related to Hematological cancer stem cells (HCSCs) that can be considered for the improvement of therapeutic interventions.

Summary: Targeting HCSCs represents one of the most promising advances toward achieving lasting remission and potential cure in hematologic malignancies. Next-generation immunotherapies—enabled by advances in molecular profiling, synthetic biology, and systems immunology—can shift the paradigm in blood cancers by overcoming current limitations.

Usage: CD117-ADC (carrying streptavidin–saporin) has shown dose-dependent results in mice, with a range from 0.3–1.5 mg/kg, as depletion of stem cells was noted with the subsequent successful engraftment of allogenic transplants.

Related Products: Streptavidin-ZAP (Cat. #IT-27), Anti-CD117-SAP (Cat. #IT-83)

Meningeal macrophages mask incision pain sensitization in male rats

Kolahdouzan M, Ghazisaeidi S, Tu Y, Muley M, Gambeta E, Salter M (2025) Meningeal macrophages mask incision pain sensitization in male rats. Mol Pain doi: 10.1177/17448069251383593

Objective: To investigate whether CD206+macrophages in the meninges play a role in regulating nociception and pain hypersensitivity.

Summary: The results indicate that while CD206+ meningeal macrophages do not regulate basal nociception in naïve rats, they mask mechanical hypersensitivity in male rats after skin incision injury. Thus, we conclude that in a sex-dependent manner, CD206+ meningeal macrophages prevent the spread of pain hypersensitivity after a minor injury.

Usage: Rats were injected intrathecally (30 μl) with saline, CD206-Saporin (20 μg mannose-receptor antibody and 7 μg of Streptavidin-ZAP in 30 μl), or Rabbit-IgG-Saporin (control).

Related Products: Streptavidin-ZAP (Cat. #IT-27), Rabbit IgG-SAP (Cat. #IT-35)

episode18

The physiological and pathological mechanisms of LIN2, LIN7, LIN10 and their tripartite complex

Shang Y, Gan X, Dang Y, Liu J, Liu P (2025) The physiological and pathological mechanisms of LIN2, LIN7, LIN10 and their tripartite complex. J Cell Mol Med 29(15):e70794. doi: 10.1111/jcmm.70794 PMID: 40801824

Objective: To furnish a robust theoretical foundation for the prospective utilization of polarity proteins and their complex as cancer markers and therapeutic targets.

Summary: Authors have found that LIN2, LIN7, and LIN10, as well as their complexes, play important roles in the establishment and maintenance of apical-basal polarity. They are also involved in two physiological processes: synaptic transmission and receptor localization. Additionally, LIN2, LIN7, and LIN10 are linked to the pathological processes of type 2 diabetes mellitus and cardiovascular diseases. Meanwhile, they regulate the proliferation, apoptosis, and metastasis of cancer cells through various pathways.

Usage: The PDZ domain of LIN2 can target binding to CD98, a negative prognostic marker for human glioblastoma cells. Constructing a chimera of the PDZ domain of LIN2 with the ribosome-inactivating protein Saporin (PR-01) and enhancing the activity of this chimera as the number of PDZ domains increases can effectively increase cytotoxicity and apoptosis in human glioblastoma cells, GL15 and U87.

Related Products: Saporin (Cat. #PR-01)

Alteration of BDNF and noradrenergic markers in locus coeruleus in a mouse model of cancer-induced bone pain

Yuan M, Zhang L, Zhu H, Xie M (2025) Alteration of BDNF and noradrenergic markers in locus coeruleus in a mouse model of cancer-induced bone pain. PLoS One 20(8):e0330207. doi: 10.1371/journal.pone.0330207 PMID: 40811566

Objective: To examine the expression and localization of BDNF and NE neuron-specific proteins in the locus coeruleus (LC) of mice with cancer-induced bone pain (CIBP).

Summary: CIBP mice exhibited enhanced neuronal activity in the LC, upregulation of noradrenergic markers, and BDNF/TrkB-mediated modulation of noradrenergic neurons. Concurrently, inhibitory signalling was attenuated in the spinal dorsal horn (SDH).

Usage: Selective ablation of noradrenergic neurons via intracerebroventricular anti-DBH-SAP (IT-03) administration reduces mechanical and cold allodynia, suggesting that LC-spinal cord pathway activity is critical for pain modulation.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

See Also:

Nanoparticle-based delivery strategies for combating drug resistance in cancer therapeutics

Park S, Lu GL, Zheng YC, Davison EK, Li Y (2025) Nanoparticle-based delivery strategies for combating drug resistance in cancer therapeutics. Cancers (Basel) 17(16):2628. doi: 10.3390/cancers17162628 PMID: 40867257

Objective: To explore how nanoparticle-based drug delivery systems can address the challenge of resistance to chemotherapy and targeted therapy by improving drug accumulation in tumors, enhancing targeting specificity, and enabling controlled or stimulus-responsive drug release.

Summary: Nanoparticle-based drug delivery strategies offer a promising and multifaceted approach to overcoming multidrug resistance in cancer therapy. Nanocarriers can address many limitations and challenges associated with conventional chemotherapy by enhancing the intracellular drug accumulation at tumor sites, bypassing efflux transporters, facilitating targeted delivery, and enabling in vivo gene modulation.

Usage: Lipid-saporin nanoparticles were utilized to bypass efflux transporters via the co-delivery of anticancer drugs with ABC transporters, leading to an increase in intracellular drug concentrations and the re-sensitization of drug-resistant cancer cells to chemotherapy.

Related Products: Saporin (Cat. #PR-01)

Shopping Cart
Scroll to Top